Monday, September 14, 2026

A New Hair-Growth Pathway?: JW0061 Targets GFRA1 After 7.2x Organoid Results and a 39% Animal Boost

JW Pharmaceutical's hair loss treatment JW0061 gains FDA approval for clinical trials, promising innovative growth stimulation for men and women.

Xi Jinping Rolls Out the Red Carpet for Kim Jong Un: A Show of Strength in China-North Korea Relations

Xi Jinping warmly welcomed Kim Jong-un during their first meeting in six years, highlighting their close relationship.

Hyundai, Kia Face a $3.75B Hit if U.S. Tariffs Return to 25%: What Should Seoul Do Next?

U.S. tariffs on Korean cars may rise to 25%, threatening Hyundai and Kia's profits with potential losses exceeding $3.75 billion.

Tag: sale

North KoreaKoreaKimMilitaryAISouth Koreamarketrelationsdevelopment

Samchundang Pharma CEO Claims FDA Recognition for Obesity Drug as Generic

Samchundang Pharma's CEO announces FDA recognition of oral semaglutide as a generic and withdraws $1.7 billion stock sale plan.

Samchundang Pharm Announces 250 Billion KRW Stake Sale…Expectations Rise for Future Growth

Samchundang Pharm's CEO plans a 2.5 billion KRW share sale for tax purposes, hinting at significant news and future growth in pharma.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.